Marathon Digital Holdings Announces Bitcoin Production and Mining Operation Updates for February 2024
– Increased Energized Hash Rate 9% M/M to 28.7 EH/s – Increased BTC Holdings to 16,930 BTC; Total Cash and […]
ThreeD Capital Inc. Announces Private Placement with Sariel Diagnostics Corp.
TORONTO, March 05, 2024 (GLOBE NEWSWIRE) — ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF), a Canadian-based venture capital […]
TSX News -
Calian Strengthens Nuclear Capability with Acquisition of MDA Ltd. Nuclear Assets
OTTAWA, March 05, 2024 (GLOBE NEWSWIRE) — Calian Group Ltd. (TSX: CGY), a diverse products and services company providing innovative […]
Opthea to Participate in the Leerink Partners Global Biopharma Conference
MELBOURNE, Australia, March 05, 2024 (GLOBE NEWSWIRE) — Opthea Limited (ASX:OPT; NASDAQ:OPT; “Opthea”), a clinical-stage biopharmaceutical company developing novel therapies […]
Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
Reports full year 2023 revenue of $50.6 million and non-GAAP adjusted EBITDA loss of $11.6 million Reaffirms expected release of […]
North American Construction Group Ltd. Announces Significant Five-Year Contract Extension in Australia
ACHESON, Alberta, March 05, 2024 (GLOBE NEWSWIRE) — North American Construction Group Ltd. (“NACG” or “the Company”) (TSX:NOA.TO/NYSE:NOA) today announced […]
Landsea Homes Announces Secondary Common Stock Offering
DALLAS, March 05, 2024 (GLOBE NEWSWIRE) — Landsea Homes Corporation (Nasdaq: LSEA) (“Landsea Homes” or the “Company”), a publicly traded […]
Topicus.com Coöperatief U.A. and Topicus.com Inc. declare a special dividend
TORONTO, March 05, 2024 (GLOBE NEWSWIRE) — Topicus.com Inc. (the “Company”) (TSXV: TOI), announced today the declaration by its subsidiary […]
Immuneering to Present Preclinical Data on Universal-RAS Program IMM-1-104 at American Association for Cancer Research Annual Meeting 2024
CAMBRIDGE, Mass., March 05, 2024 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop and […]
W&T Offshore Announces Fourth Quarter and Full Year 2023 Results Including Year-End 2023 Proved Reserves, Provides Guidance for 2024, and Declares Dividend for First Quarter of 2024
HOUSTON, March 05, 2024 (GLOBE NEWSWIRE) — W&T Offshore, Inc. (NYSE: WTI) (“W&T” or the “Company”) today reported operational and […]
